High Yield Revival: 3 Cash-Rich Dividend Payers on Sale
Amid market volatility and a rotation out of high-growth tech stocks, investors are now prioritizing dividend-paying stocks with steady cash flows for reliable income. This article highlights three cash-rich dividend payers: Omega Healthcare Inc. (OHI), Perrigo Company (PRGO), and Omnicom Group Inc. (OMC), which offer attractive yields above the Invesco S&P 500 High Dividend Low Volatility ETF (SPHD). These companies provide stability and income potential for investors seeking value in a changing market landscape, with detailed reasons for their appeal.
Omega Healthcare Investors, Inc. $OHI Shares Bought by Advisors Capital Management LLC
Advisors Capital Management LLC increased its stake in Omega Healthcare Investors, Inc. ($OHI) by 3.5% in the third quarter, now holding 918,091 shares worth approximately $38.8 million. Omega Healthcare recently paid a quarterly dividend of $0.67, representing a 5.6% yield, and analysts currently have a "Moderate Buy" consensus rating with an average price target of $47.36. The company, a real estate investment trust specializing in healthcare facilities, has a market cap of $14.13 billion and a P/E ratio of 24.78.
Omega Healthcare Investors (NYSE:OHI) Hits New 52-Week High - Still a Buy?
Omega Healthcare Investors (NYSE:OHI) recently reached a new 52-week high of $47.94. The company maintains a "Moderate Buy" consensus rating from MarketBeat with a target price of $47.36, and has seen mixed analyst adjustments including a positive "overweight" rating and $52 target from Cantor Fitzgerald. OHI declared a quarterly dividend of $0.67 per share, yielding 5.6%, though its dividend payout ratio is high at 138.86%.
(OHI) as a Liquidity Pulse for Institutional Tactics
This article analyzes Omega Healthcare Investors Inc. (NYSE: OHI) from an institutional trading perspective, highlighting strong sentiment across all horizons which supports an overweight bias. It presents various AI-generated trading strategies including position, momentum breakout, and risk-hedging, complete with entry, target, and stop-loss levels. The report also provides multi-timeframe signal analysis, identifying support and resistance levels for near-term, mid-term, and long-term horizons, and offers access to real-time signals and custom risk models.
Envestnet Asset Management Inc. Acquires 72,652 Shares of Omega Healthcare Investors, Inc. $OHI
Envestnet Asset Management Inc. increased its stake in Omega Healthcare Investors (NYSE:OHI) by 17.4% in the third quarter, acquiring 72,652 additional shares and bringing its total holdings to 490,217 shares valued at approximately $20.7 million. Omega Healthcare Investors recently declared a quarterly dividend of $0.67 per share, yielding 5.7% annually, with an ex-dividend date of February 9th. The stock currently holds a "Moderate Buy" consensus rating from analysts, with a target price of $47.36.
LSV Asset Management Has $54.04 Million Holdings in Omega Healthcare Investors, Inc. $OHI
LSV Asset Management reduced its stake in Omega Healthcare Investors (NYSE:OHI) by 10.6% in the third quarter, now holding 1.28 million shares valued at $54.04 million. Other institutional investors also adjusted their positions, with overall institutional ownership at 65.25%. The company recently declared a quarterly dividend of $0.67 per share, yielding 5.7%, and analysts have a "Moderate Buy" consensus rating with an average target price of $47.36.
Omega Healthcare Investors, Inc. $OHI Shares Purchased by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. significantly increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 765% in Q3, now holding 86,651 shares valued at $3,658,000. The company recently announced a quarterly dividend of $0.67 per share, yielding 5.7%, payable on February 17th. While analysts have mixed opinions, the consensus rating is "Moderate Buy" with a target price of $47.36, despite recent downgrades from BMO and Wells Fargo.
Omega Healthcare Investors stock hits all-time high at 46.38 USD By Investing.com
Omega Healthcare Investors Inc. (OHI) has reached an all-time high of $46.38, reflecting strong investor confidence with a 34.74% increase over the past year and a 5.9% dividend yield. The company also reported strong Q4 2025 earnings, surpassing Wall Street expectations, and received a raised price target from Cantor Fitzgerald. These developments highlight OHI's solid financial health and strategic positioning in the healthcare REIT sector.
RBC Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $47
RBC Capital analyst Michael Carroll has maintained a 'hold' rating on Omega Healthcare Investors Inc (OHI.US) and increased the target price from $44 to $47. According to TipRanks data, Carroll has a 61.5% success rate and a 7.5% average return over the past year. This report highlights key financial analyst insights from TipRanks, noting that the information is for informational purposes and not investment advice.
Cantor Fitzgerald raises Omega Healthcare price target to $52 on strong growth
Cantor Fitzgerald has increased its price target for Omega Healthcare Investors (NYSE:OHI) to $52.00 from $50.00, maintaining an Overweight rating due to strong external growth and rent coverage improvements. The company's stock is currently trading near its 52-week high after a 29.79% return over the past year, and it recently surpassed Q4 2025 earnings and revenue expectations. Cantor Fitzgerald anticipates continued capital deployment and potential guidance raises for Omega Healthcare.
Cantor Fitzgerald raises Omega Healthcare price target to $52 on strong growth
Cantor Fitzgerald raised its price target for Omega Healthcare Investors (NYSE:OHI) to $52.00 from $50.00, reiterating an Overweight rating. This increase follows a strong year of external growth and rent coverage improvements in 2025, with over $200 million in new investments in early 2026. The firm projects continued accretive capital deployment and "very beatable" 4.4% year-over-year adjusted FFO growth for 2027.
Cantor Fitzgerald Forecasts Strong Price Appreciation for Omega Healthcare Investors (NYSE:OHI) Stock
Cantor Fitzgerald has raised its price target for Omega Healthcare Investors (OHI) from $50 to $52, maintaining an "overweight" rating and suggesting a 15.54% upside. This positive outlook is echoed by other analysts, resulting in a "Moderate Buy" consensus and an average target price of $47.09 for the healthcare REIT. The article also highlights OHI's current stock performance, institutional ownership, and company profile as a real estate investment trust specializing in healthcare facilities.
RBC Raises Price Target on Omega Healthcare Investors to $47 From $44, Keeps Sector Perform Rating
RBC has increased its price target for Omega Healthcare Investors (OHI) to $47 from $44, while maintaining a Sector Perform rating. This adjustment follows recent activities including UBS also updating its price target for OHI to $52 with a Buy rating, and Omega Healthcare Investors reporting Q4 2025 earnings where AFFO and revenue rose. The company also provided a full-year 2026 AFFO guidance and announced recent acquisitions of healthcare facilities.
How Investors Are Reacting To Omega Healthcare Investors (OHI) Strong 2025 Results, Investments, Debt Cuts And Dividend
Omega Healthcare Investors (OHI) reported strong financial results for 2025, including increased revenue, net income, and a maintained dividend, while also making significant investments and debt repayments. Despite operator-specific challenges, these results reinforce the company's ability to fund its payout. Investors are now evaluating the company's investment narrative, considering both its earnings growth and the risks associated with tenant issues and regulatory oversight.
BofA Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Maintains Target Price $48
BofA Securities analyst Farrell Granath has maintained a "hold" rating for Omega Healthcare Investors Inc (OHI.US), with a target price of $48. Granath has a 76.9% success rate and an average return of 2.5% over the past year, according to TipRanks data. TipRanks provides independent analysis of financial analysts' performance based on their recommendations.
OMEGA HEALTHCARE INVESTORS INC SEC 10-K Report
Omega Healthcare Investors, Inc. (OHI) has released its 2025 Form 10-K report, showcasing robust financial performance with total revenue of $1.19 billion and net income of $609 million, alongside strategic acquisitions and new market expansions in the U.K. and Canada. The report details the company's extensive portfolio of healthcare facilities and its focus on strategic growth through acquisitions and joint ventures, while also addressing challenges like staffing shortages, regulatory changes, and operator performance risks in the healthcare real estate sector. Omega plans to continue evaluating investments, including RIDEA structures and alternative jurisdictions, to diversify its portfolio and leverage strong demand for skilled nursing care.
How Investors Are Reacting To Omega Healthcare Investors (OHI) Strong 2025 Results, Investments, Debt Cuts And Dividend
Omega Healthcare Investors (OHI) reported strong financial results for Q4 and full-year 2025, with increased revenue, net income, and a maintained dividend. The company also made significant investments and repaid substantial debt, despite facing operator-specific challenges. This article explores how these developments impact OHI's investment narrative, highlighting its focus on long-term demand for skilled nursing and senior care, balanced against risks like operator stress and regulatory hurdles.
Omega Healthcare Investors Adjusts Evaluation Amid Mixed Technical and Strong Fundamental Indicators
Omega Healthcare Investors has received an adjusted evaluation, reflecting a blend of mixed technical signals and strong fundamental indicators. While some technical aspects show a mildly bearish or neutral outlook, the company boasts robust fundamentals, including a solid Return on Equity of 10.36% and a low debt-equity ratio of 84.89%. Despite modest net sales growth, its strong financial position underpins its long-term strength.
Senior living and care industry remains ‘quite fragile’ but on road to recovery: Omega CEO
Omega Healthcare Investors' CEO Taylor Pickett stated that despite a hit to its bottom line in Q1 due to operator restructurings, the senior living and care industry is on the path to recovery, albeit remaining "quite fragile." The company expects financial performance to improve as restructurings conclude, operators resume rent payments, and asset sales proceeds are redeployed. Occupancy is increasing, labor markets are moderating, and reimbursement rates are providing support, indicating positive trends for the industry.
Omega Healthcare Investors expects 2025 momentum to carry into new year
Omega Healthcare Investors anticipates that the strong momentum from 2025, driven by strategic acquisitions and portfolio management, will continue into 2026. CEO Taylor Pickett highlighted significant investments made in 2025, including acquisitions of senior living communities and a major investment in a joint venture with Saber Healthcare Holdings. The company is actively expanding its relationships and investment structures, with a focus on maximizing returns across various asset classes like US senior living, UK care homes, and skilled nursing facilities.
Omega Healthcare Investors (OHI) FFO Growth Reinforces Bullish Income Narratives For FY 2025
Omega Healthcare Investors (OHI) reported strong financial results for FY 2025, with Q4 revenue of US$319.2 million and basic EPS of US$0.55. The company's net profit margin reached 49.6%, and FFO grew notably, reinforcing a bullish income narrative for investors. Despite solid trailing FFO per share and a discounted P/E compared to peers, future growth forecasts are modest, with expected annual earnings growth of only 4.6% and a 0.4% revenue decline, while high debt remains a concern.
Earnings call transcript: Omega Healthcare beats Q4 2025 expectations, stock rises
Omega Healthcare Investors Inc. (OHI) exceeded Q4 2025 expectations with an EPS of $0.55 and revenue of $319 million, leading to a 4.82% stock increase. The company reduced its fueled debt by over $700 million and provided optimistic guidance for 2026, projecting adjusted FFO between $3.15 and $3.25 per share, demonstrating strong financial health and strategic growth. The earnings call detailed the company's performance, new investments, and plans, including expansions into Canada and RIDEA structures.
Omega Healthcare Investors (OHI) Tops Q4 FFO and Revenue Estimates
Omega Healthcare Investors (OHI) reported quarterly funds from operations (FFO) of $0.8 per share, exceeding the Zacks Consensus Estimate of $0.79, and revenues of $319.22 million, also surpassing estimates. Despite outperforming FFO expectations in three of the last four quarters, OHI shares have seen a 3.2% decline year-to-date. The stock currently holds a Zacks Rank #2 (Buy), indicating potential for market outperformance.
Omega Healthcare Investors (NYSE:OHI) Posts Earnings Results, Beats Expectations By $0.01 EPS
Omega Healthcare Investors (NYSE:OHI) reported Q1 earnings per share of $0.80, surpassing the consensus estimate by $0.01. The company announced a quarterly dividend of $0.67, representing a 6.2% yield, and saw its stock trade up by $0.01 to $42.94. Insider CIO Vikas Gupta recently increased his stake, while institutional investors hold a significant portion of the company's stock, and analysts maintain a "Moderate Buy" rating with an average price target of $46.82.
(OHI) Omega Healthcare Investors Expects Full Year 2026 AFFO Range $3.15 - $3.25, vs. FactSet Est of $3.21
Omega Healthcare Investors Inc. (OHI) has announced its Adjusted Funds From Operations (AFFO) forecast for the full year 2026, expecting a range of $3.15 to $3.25 per share. This projection falls closely in line with FactSet's estimated AFFO of $3.21 per share. The company also reported Q4 2025 revenues of $319.2 million, significantly exceeding FactSet's estimate of $264.5 million, and Q4 AFFO of $0.80 per share, surpassing the FactSet estimate of $0.76 per share.
Omega Healthcare Q4 earnings beat; issues solid guidance (OHI:NYSE)
Omega Healthcare Investors (OHI) reported stronger-than-expected Q4 2025 earnings and revenue, with adjusted FFO per share and revenue surpassing analyst estimates. The healthcare REIT also issued solid guidance for 2026, with a midpoint for adjusted FFO per share modestly above the Wall Street consensus. The company's operational developments included significant new investments, facility sales, and acquisitions, while operator rent payments remained current.
Omega Reports Fourth Quarter and Full Year 2025 Results and Recent Developments
Omega Healthcare Investors, Inc. (NYSE: OHI) announced its financial results for Q4 and the full year 2025, highlighting strong performance with increased Adjusted Funds From Operations (AFFO) per share and significant new investments totaling $1.0 billion. The company also reported a reduction in leverage to its lowest historical level and provided 2026 AFFO guidance of $2.05 to $2.15 per diluted share. A quarterly cash dividend of $0.67 per share has been declared.
Earnings Flash (OHI) Omega Healthcare Investors, Inc. Reports Q4 Revenue $319.2M, vs. FactSet Est of $264.5M
Omega Healthcare Investors, Inc. (OHI) reported its Q4 revenue at $319.2 million, significantly surpassing FactSet's estimate of $264.5 million. The company is a real estate investment trust specializing in healthcare properties in the US and UK, focusing on skilled nursing and assisted living facilities. This positive revenue surprise comes amidst recent acquisitions and analyst rating adjustments, maintaining investor interest in the stock.
Omega Healthcare earnings on deck after blowout third quarter
Omega Healthcare Investors Inc. is scheduled to release its fourth-quarter results, with analysts expecting 49 cents per share on revenue of $262.2 million, a decline from the strong third quarter. Investors will focus on the health of Omega's tenant base, its acquisition pipeline, and explanations for the expected sequential revenue drop. The stock currently trades closer to the middle of its 52-week range, with analyst ratings split between Buy and Hold.
(OHI) Risk Channels and Responsive Allocation
The article provides an analysis of Omega Healthcare Investors Inc. (NYSE: OHI), highlighting a divergent sentiment across time horizons and a challenging support level. It presents three AI-generated trading strategies—position, momentum breakout, and risk hedging—along with multi-timeframe signal analysis to guide investors. Key findings suggest a significant risk-reward setup with potential for a 5.2% gain against minimal risk.
Omega Healthcare Investors, Inc. $OHI Shares Purchased by Mutual Advisors LLC
Mutual Advisors LLC increased its stake in Omega Healthcare Investors (OHI) by 8.5% in the third quarter, reporting ownership of 327,383 shares. Other significant institutional investors like Norges Bank, Hudson Bay Capital Management LP, Lasalle Investment Management Securities LLC, Vanguard Group Inc., and Sumitomo Mitsui Trust Group Inc. also made substantial purchases or increased their positions. Insiders, including CIO Vikas Gupta and CEO C. Taylor Pickett, recently bought shares, boosting insider ownership to about 1.50%.
Bank of New York Mellon Corp Grows Stock Holdings in Omega Healthcare Investors, Inc. $OHI
Bank of New York Mellon Corp increased its stake in Omega Healthcare Investors (NYSE:OHI) by 6.8% in Q3, now owning 3,761,216 shares valued at approximately $158.8 million. Omega Healthcare Investors exceeded Q3 earnings expectations, reporting an EPS of $0.79 against a forecast of $0.77, with revenue up 14.4% year-over-year. The company announced a quarterly dividend of $0.67, with an annualized yield of 6.1%.
Is Omega Healthcare Investors' (OHI) Steady Dividend Masking Deeper Long‑Term Care Tenant Fragilities?
Omega Healthcare Investors (OHI) declared a cash dividend of US$0.67 per share, payable on February 17, 2026. This dividend, combined with a recent Wells Fargo downgrade and ongoing tenant risks, highlights the complex investment narrative for OHI. Investors should consider the reliance of this dividend on the operating health of long-term care tenants and weigh various viewpoints on the stock's valuation.
Omega Healthcare Investors declares $0.67 per share dividend By Investing.com
Omega Healthcare Investors (NYSE:OHI) announced a quarterly cash dividend of $0.67 per share, payable on February 17, 2026, to stockholders of record as of February 9, 2026. The real estate investment trust specializes in long-term healthcare facilities. This announcement follows recent positive Q3 2025 core FFO results and varied analyst ratings, with UBS and Goldman Sachs initiating Buy ratings, while BMO Capital downgraded and Truist Securities maintained a Hold.
Is Omega Healthcare Investors' (OHI) Steady Dividend Masking Deeper Long‑Term Care Tenant Fragilities?
Omega Healthcare Investors (OHI) recently declared an unchanged cash dividend of US$0.67 per share, payable on February 17, 2026. This stable dividend, however, comes amid a Wells Fargo downgrade due to valuation concerns and ongoing risks related to its long-term care tenants. Investors are encouraged to consider the company's reliance on tenant operating strength and diverse fair value estimates when evaluating the stock.
Omega Healthcare Investors, Inc. (NYSE:OHI) Plans Quarterly Dividend of $0.67
Omega Healthcare Investors (NYSE:OHI) has declared a quarterly dividend of $0.67 per share, totaling an annualized $2.68, payable on February 17th to shareholders of record on February 9th. Although the current payout ratio of 148.1% indicates the dividend is not covered by current earnings, analysts
Omega Healthcare Investors declares $0.67 per share dividend By Investing.com
Omega Healthcare Investors (NYSE: OHI) announced that its Board of Directors has declared a quarterly cash dividend of $0.67 per share, payable on February 17, 2026, to shareholders of record as of February 9, 2026. The company, a real estate investment trust specializing in long-term healthcare, recently reported core FFO of $0.79 per share for Q3 2025, exceeding analyst estimates. Analyst ratings for Omega Healthcare vary, with UBS and Goldman Sachs initiating 'Buy' ratings, BMO Capital downgrading to 'Market Perform,' and Truist Securities and Citizens maintaining 'Hold' and 'Market Perform' ratings respectively.
Omega Healthcare Investors declares $0.67 per share dividend By Investing.com
Omega Healthcare Investors, Inc. (NYSE:OHI) has declared a quarterly cash dividend of $0.67 per share, payable on February 17, 2026, to stockholders of record as of February 9, 2026. The real estate investment trust specializes in long-term healthcare, investing in skilled nursing and assisted living facilities. This announcement follows recent positive reports regarding the company's core FFO and several analyst ratings, including Buy ratings from UBS and Goldman Sachs, alongside some Market Perform and Hold ratings.
Omega Healthcare Investors Maintains Quarterly Dividend at $0.67 a Share, Payable Feb. 17 to Stockholders of Record Feb. 9
Omega Healthcare Investors has announced it will maintain its quarterly dividend at $0.67 per share. The dividend is scheduled to be paid on February 17, 2026, to shareholders who are on record as of February 9, 2026. This news was published on January 29, 2026, at 03:18 pm EST.
Is Omega Healthcare Investors (OHI) Attractive After Recent Share Price Pullback?
Omega Healthcare Investors (OHI) has experienced recent short-term share price declines but shows strong longer-term returns. Simply Wall St's analysis, using discounted cash flow and price-to-earnings ratios, suggests that OHI is currently undervalued. The article highlights that OHI is trading significantly below its estimated intrinsic value and below its "Fair Ratio" P/E.
Wells Fargo Downgrades Omega Healthcare Investors Inc(OHI.US) to Hold Rating, Cuts Target Price to $45
Wells Fargo analyst John Kilichowski has downgraded Omega Healthcare Investors Inc (OHI.US) to a hold rating and reduced the target price from $48 to $45. This decision is based on TipRanks data, which indicates the analyst has a 42.6% success rate and a 1.6% average return over the past year. Investors should note this information is for educational purposes and not an investment recommendation.
Omega Healthcare Investors (NYSE:OHI) Lowered to Equal Weight Rating by Wells Fargo & Company
Wells Fargo & Company downgraded Omega Healthcare Investors (NYSE:OHI) from an "overweight" to an "equal weight" rating, setting a $45 price target. This re-rating comes despite Omega Healthcare Investors beating Q3 earnings and revenue expectations, displaying a 14.4% year-over-year revenue increase. The company maintains a "Moderate Buy" consensus rating from analysts, and recent insider purchases indicate management's confidence in the stock.
Omega Healthcare Investors declares $0.67 per share dividend By Investing.com
Omega Healthcare Investors (NYSE:OHI) announced a quarterly cash dividend of $0.67 per share, payable on February 17, 2026, to stockholders of record as of February 9, 2026. The real estate investment trust specializes in healthcare facilities and recently reported strong core FFO for Q3 2025. Analyst ratings are varied, with UBS and Goldman Sachs initiating Buy ratings, BMO Capital downgrading to Market Perform, and Truist Securities maintaining a Hold rating.
The Truth About Omega Healthcare Investors (OHI): Safe Dividends or Silent Trap?
This article examines Omega Healthcare Investors (OHI), a healthcare REIT, focusing on its appeal to dividend investors. While OHI offers a high dividend yield due to its REIT structure and addresses the growing demand for long-term care, it also carries risks associated with the financial stability of its nursing home tenants. The piece concludes by positioning OHI as a solid choice for income-focused investors comfortable with tenant-related risks, rather than those seeking high-growth or meme-stock-like returns.
The Truth About Omega Healthcare Investors (OHI): Safe Dividends or Silent Trap?
Omega Healthcare Investors (OHI) is gaining attention among dividend investors due to its high yield and focus on healthcare real estate like nursing homes. While presented as a steady cash generator for income-focused portfolios, the article highlights risks associated with tenant financial stability and the broader healthcare regulatory environment. Investors are advised to weigh the attractive dividend against potential volatility and dependence on the long-term viability of the senior care sector.
Strs Ohio Sells 23,613 Shares of Omega Healthcare Investors, Inc. $OHI
Strs Ohio reduced its holdings in Omega Healthcare Investors by 6.9%, selling 23,613 shares, though the company remains a "Moderate Buy" according to MarketBeat consensus. Despite institutional trimming, Omega Healthcare's CIO and CEO recently increased their personal stakes. The company exceeded Q3 earnings estimates and provided optimistic FY2025 guidance.
Omega Healthcare Investors, Inc. $OHI Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Omega Healthcare Investors (NYSE: OHI) by 30% in Q3, now owning 390,482 shares valued at approximately $16.49 million. The company reported strong Q3 earnings, beating analyst estimates with $0.79 EPS and $311.6 million in revenue, and insiders, including the CEO and CIO, have made significant share purchases. Analysts maintain a "Moderate Buy" rating with a consensus target price of $47.09 for OHI.
Are You Looking for a Top Momentum Pick? Why Omega Healthcare Investors (OHI) is a Great Choice
Omega Healthcare Investors (OHI) is highlighted as a top momentum pick by Zacks Equity Research, boasting a Momentum Style Score of A and a Zacks Rank #2 (Buy). The article details OHI's strong short-term and long-term price performance, outperforming both its industry and the S&P 500. Additionally, positive earnings estimate revisions further contribute to its promising outlook for investors seeking near-term growth.
Omega Healthcare Investors (OHI) Upgraded to Buy: Here's Why
Omega Healthcare Investors (OHI) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in its earnings estimates. This upgrade suggests a positive outlook on the company's financial future, which often leads to increased stock prices. The Zacks Rank system, which correlates earnings estimate revisions with stock movements, indicates that OHI is among the top 20% of Zacks-covered stocks.
Omega Healthcare Investors Breakout Highlights Undervalued Healthcare REIT Opportunity
Omega Healthcare Investors (NYSE:OHI) is showing a strong technical breakout, attracting renewed investor interest in healthcare REITs. The shares are currently trading at $45.04, below the analyst target midpoint of $47.13, and are flagged as undervalued by Simply Wall St. While the company's debt coverage by operating cash flow is a risk, its recent momentum and P/E ratio position it as a potential opportunity for both income and price-focused investors.
